ERAL1 and neoplasm: To conclude, this present work demonstrates that: 1) both nuclear and membrane stromal ERα modulate ER-negative tumor growth and that these effects of E2 are antagonized by tamoxifen; 2) tamoxifen blocks angiogenesis by altering the angiogenic growth factors, and endothelial metabolism, using a specific transcriptional program and key transcription factors.